Cargando…
The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway
BACKGROUND: Antimicrobial Stewardship is a coordinated effort to improve and measure the appropriate use of antimicrobials. Antibiotic resistance is an emerging world health problem and unnecessary prescribing of broad-spectrum antibiotics is a major contributor to this. Skin and soft-tissue infecti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107068/ http://dx.doi.org/10.1093/ofid/ofx163.1322 |
_version_ | 1783512738068168704 |
---|---|
author | Dalziel, Andrew Smyth, Daniel Ghaly, Ahmed MacLaggan, Timothy Stoica, George |
author_facet | Dalziel, Andrew Smyth, Daniel Ghaly, Ahmed MacLaggan, Timothy Stoica, George |
author_sort | Dalziel, Andrew |
collection | PubMed |
description | BACKGROUND: Antimicrobial Stewardship is a coordinated effort to improve and measure the appropriate use of antimicrobials. Antibiotic resistance is an emerging world health problem and unnecessary prescribing of broad-spectrum antibiotics is a major contributor to this. Skin and soft-tissue infections are a common reason to receive a prescription for antibiotics. Currently there exists a trend for using broad-spectrum intravenous antibiotics for moderate to severe infections when more narrow-spectrum options would be adequate. This study aimed to characterize the choice of antibiotic being prescribed for the management of outpatient cellulitis requiring intravenous antibiotics and evaluate the success of a clinical order set outlining optimal therapy. METHODS: This study was a retrospective chart review looking at antibiotic prescribing through the Emergency Department at The Moncton Hospital, in Moncton, New Brunswick. Charts were reviewed before and after the introduction of a clinical order set outlining optimal antibiotic therapy. The goal was to review charts from the pre- and post-intervention group and compare antibiotic usage, treatment failure rates, and adverse events. RESULTS: Of the 54 patients receiving IV antibiotics in the pre-intervention group, 3 received cefazolin, 50 received ceftriaxone, while 1 received levofloxacin. The median duration of IV therapy was four days. After the introduction of the clinical order set there was an absolute increase of 53.8% (n = 35) in the use of cefazolin and absolute decrease of 53.7% (n = 23) in the use of ceftriaxone in the post-intervention group of 59 patients. Both results were statistically significant (P < 0.001). The median duration of IV therapy in this group was 3.5 days. In eligible patients, the clinical order set was utilized 61.1% of the time. There was no significant difference in rates of treatment failure or adverse events between cefazolin and ceftriaxone. CONCLUSION: The introduction of a clinical order set outlining the preferential use of once-daily cefazolin plus probenecid for the treatment of outpatient cellulitis lead to a statistically significant increase use of cefazolin, and decrease use of ceftriaxone, thus demonstrating a positive stewardship effect at a local level. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-7107068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71070682020-04-02 The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway Dalziel, Andrew Smyth, Daniel Ghaly, Ahmed MacLaggan, Timothy Stoica, George Open Forum Infect Dis Abstracts BACKGROUND: Antimicrobial Stewardship is a coordinated effort to improve and measure the appropriate use of antimicrobials. Antibiotic resistance is an emerging world health problem and unnecessary prescribing of broad-spectrum antibiotics is a major contributor to this. Skin and soft-tissue infections are a common reason to receive a prescription for antibiotics. Currently there exists a trend for using broad-spectrum intravenous antibiotics for moderate to severe infections when more narrow-spectrum options would be adequate. This study aimed to characterize the choice of antibiotic being prescribed for the management of outpatient cellulitis requiring intravenous antibiotics and evaluate the success of a clinical order set outlining optimal therapy. METHODS: This study was a retrospective chart review looking at antibiotic prescribing through the Emergency Department at The Moncton Hospital, in Moncton, New Brunswick. Charts were reviewed before and after the introduction of a clinical order set outlining optimal antibiotic therapy. The goal was to review charts from the pre- and post-intervention group and compare antibiotic usage, treatment failure rates, and adverse events. RESULTS: Of the 54 patients receiving IV antibiotics in the pre-intervention group, 3 received cefazolin, 50 received ceftriaxone, while 1 received levofloxacin. The median duration of IV therapy was four days. After the introduction of the clinical order set there was an absolute increase of 53.8% (n = 35) in the use of cefazolin and absolute decrease of 53.7% (n = 23) in the use of ceftriaxone in the post-intervention group of 59 patients. Both results were statistically significant (P < 0.001). The median duration of IV therapy in this group was 3.5 days. In eligible patients, the clinical order set was utilized 61.1% of the time. There was no significant difference in rates of treatment failure or adverse events between cefazolin and ceftriaxone. CONCLUSION: The introduction of a clinical order set outlining the preferential use of once-daily cefazolin plus probenecid for the treatment of outpatient cellulitis lead to a statistically significant increase use of cefazolin, and decrease use of ceftriaxone, thus demonstrating a positive stewardship effect at a local level. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC7107068/ http://dx.doi.org/10.1093/ofid/ofx163.1322 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Dalziel, Andrew Smyth, Daniel Ghaly, Ahmed MacLaggan, Timothy Stoica, George The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway |
title | The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway |
title_full | The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway |
title_fullStr | The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway |
title_full_unstemmed | The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway |
title_short | The Management of Outpatient Cellulitis at The Moncton Hospital before and after the Initiation of a Clinical Treatment Pathway |
title_sort | management of outpatient cellulitis at the moncton hospital before and after the initiation of a clinical treatment pathway |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107068/ http://dx.doi.org/10.1093/ofid/ofx163.1322 |
work_keys_str_mv | AT dalzielandrew themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT smythdaniel themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT ghalyahmed themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT maclaggantimothy themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT stoicageorge themanagementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT dalzielandrew managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT smythdaniel managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT ghalyahmed managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT maclaggantimothy managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway AT stoicageorge managementofoutpatientcellulitisatthemonctonhospitalbeforeandaftertheinitiationofaclinicaltreatmentpathway |